Huayi Technology Concludes SNMMI 2025

New Orleans, June 24, 2025 – The 2025 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2025) successfully concluded today in New Orleans, USA. As a premier global gathering in the field, SNMMI consistently brings together cutting-edge scientific research and technological advancements.

Jiangsu Huayi Technology Co., Ltd. (Huayi Technology) was honored to participate once again in this year's event. At Booth #1923, the company presented its key products and solutions, engaging with global peers to discuss emerging trends in nuclear medicine.

Under the theme "Breakthrough Science and Clinical Innovation," SNMMI 2025 highlighted critical areas including:

● Theranostics (Integrated Diagnostics and Therapy)

● Novel Radiopharmaceuticals and Targeted Biomarkers

● Innovation and AI-Enabled Advancements in Nuclear Medicine Equipment

● Global Supply Chain Dynamics and Collaborative Models

As a participant in China's radiopharmaceutical sector, Huayi Technology has attended SNMMI for multiple consecutive years, seeking to share the company's progress in innovation and integrated service capabilities with the international community.

During the exhibition, Huayi Technology shared information on:

● Comprehensive Radiopharmaceutical Solutions

● Medical Stable Isotopes and Supporting Consumables

● Radiopharmaceutical CDMO (RCDMO) Services

● Diversified product offerings for international markets

The event provided a valuable opportunity for the Huayi Technology team to strengthen relationships with existing international clients and partners, supporting the company's ongoing efforts to expand its global presence.

Huayi Technology sincerely appreciates the colleagues, partners, and friends who visited our booth for their insights and constructive discussions. We are grateful for your continued interest and support and look forward to future opportunities for collaboration.